Pemigatinib(Pemazyre)

Another Name佩米替尼、培美替尼、LuciPem、pemazyre

IndicationsAdult patients with FGFR2-altered, previously treated unresectable locally advanced/metastatic cholangiocarcinoma (confirmed via FDA-approved test).